Module
Long-Term Management of Patients with Chronic Hepatitis B Virus Infection
Source: Diagnosis, Treatment, and Chronic Care Options for Hepatitis B
Long-Term Management of Patients with Chronic Hepatitis B Virus Infection
CME Program Director: Patrick J. Lynch, MD
Program Director: Eugene R. Schiff, MD, MACP, FRCP, MACG
|
Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the safety and efficacy of currently available treatments for chronic HBV infection. Review the elements of disease assessment, counseling, monitoring, and initial treatment decisions in chronic HBV infection. Discuss the natural history of chronic HBV infection, including the clinical phases, and factors impacting disease activity and progression.
Content includes:
-
HBV Infection Is Life Long
-
Clinical Course of Chronic HBV Infection is Highly Variable
-
Immune Tolerant Phase (HBeAg-positive chronic hepatitis with normal ALT)
-
Immune Clearance Phase (HBeAg-positive chronic hepatitis)
-
Inactive Carrier State
-
Reactivation of HBV Replication (HBeAg-negative chronic hepatitis)
-
Initial Evaluation: History and Physical Examination
-
Initial Evaluation: Laboratory Tests
-
Counseling for Chronic Hepatitis B
-
When Should Hepatitis B Treatment Be Initiated?
-
Treatment Decisions in HBeAg-Positive Patients
-
Treatment Decisions in HBeAg-Negative Patients
-
Long-Term Monitoring Before Treatment
-
Long-Term Monitoring on Treatment
-
Monitoring HBeAg-Positive Patients on Treatment
-
Monitoring HBeAg-Negative Patients on Treatment
-
Monitoring Biochemical Response and Side Effects
-
Long-Term Monitoring After Treatment
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.
Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|